SCHEMBL6619746

SCHEMBL6619746

c1ccc(Oc2cnc3cc4cn[nH]c4cc3n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 7/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RAB9A P51151 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ FGFR1 P11362 2/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ CLK1 P49759 1/20 0.41
▸ CLK2 P49760 1/20 0.41
▸ CLK3 P49761 1/20 0.41
▸ GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619697 1.00 HTT (0.56) HTTALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL8112159 1.00 HTT (0.56) HTTALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6618275 0.81 CDC7 (0.43) NPSR1FGFR1DYRK3CLK1CLK2
SCHEMBL6618578 0.81 CDC7 (0.43) NPSR1FGFR1DYRK3CLK1CLK2
SCHEMBL6616216 0.80 CYSLTR1 (0.46) RAB9ANPC1FGFR1DYRK3CLK1
SCHEMBL6615880 0.80 CYSLTR1 (0.46) RAB9ANPC1FGFR1DYRK3CLK1
SCHEMBL14015135 0.78 FGFR1 (0.46) HTTALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6616738 0.75 SMN1; SMN2 (0.58) ALDH1A1CYP1A2RAB9ANPC1L3MBTL1
SCHEMBL8880504 0.73 HTT (1.00) HTTALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6618464 0.72 ROCK2 (0.49) FGFR1DYRK3CLK1CLK2CLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback